A permutation-based non-parametric analysis of CRISPR screen data
Gaoxiang Jia, Xinlei Wang, Guanghua Xiao · BMC Genomics · 2017
BACKGROUND: Clustered regularly-interspaced short palindromic repeats (CRISPR) screens are usually implemented in cultured cells to identify genes with critical functions. Although several methods have been developed or adapted to analyze CRISPR screening data, no single specific algorithm has gained popularity. Thus, rigorous procedures are needed to overcome the shortcomings of existing algorithms. METHODS: We developed a Permutation-Based Non-Parametric Analysis (PBNPA) algorithm, which computes p-values at the gene level by permuting sgRNA labels, and thus it avoids restrictive distributional assumptions. Although PBNPA is designed to analyze CRISPR data, it can also be applied to analyze genetic screens implemented with siRNAs or shRNAs and drug screens. RESULTS: We compared the performance of PBNPA with competing methods on simulated data as well as on real data. PBNPA outperformed recent methods designed for CRISPR screen analysis, as well as methods used for analyzing other functional genomics screens, in terms of Receiver Operating Characteristics (ROC) curves and False Discovery Rate (FDR) control for simulated data under various settings. Remarkably, the PBNPA algorithm showed better consistency and FDR control on published real data as well. CONCLUSIONS: PBNPA yields more consistent and reliable results than its competitors, especially when the data quality is low. R package of PBNPA is available at: https://cran.r-project.org/web/packages/PBNPA/ .
Cited by 31 works. doi:10.1186/s12864-017-3938-5 Open-access PDF
Authors
References
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
- edgeR : a Bioconductor package for differential expression analysis of digital gene expression data
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- Genetic Screens in Human Cells Using the CRISPR-Cas9 System
- baySeq: Empirical Bayesian methods for identifying differential expression in sequence count data
- Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
- Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases
- Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library